In ALS, the P2X7 receptor preferential agonist 2′-3′-O-(benzoyl-benzoyl) ATP, enhances the neurotoxic potential of SOD1-G93A microglia and increases the production of ROS through the recruitment of Rac1 and NOX2. The gene discussed is RAC1; the disease is amyotrophic lateral sclerosis.